Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Patents
Academic Access
Technology Licensing
Scientific Publications
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
07/31/2007
Lexicon Pharmaceuticals Reports 2007 Second Quarter Financial Results
07/30/2007
Lexicon Drug Candidate For Cognitive Disorders Successfully Completes Phase 1 Clinical Trial
07/18/2007
Lexicon to Report Second Quarter 2007 Financial Results on July 31, 2007
07/02/2007
Lexicon Develops Antibodies that Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
06/17/2007
Lexicon Pharmaceuticals Announces Two Agreements to Finance Long-Term Drug Development Strategy
06/07/2007
Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune Deficiency
06/06/2007
Lexicon Pharmaceuticals to Present at the Needham Biotechnology & Medical Technology Conference
05/22/2007
Lexicon Pharmaceuticals to Present at the Bank of America Health Care Conference
05/14/2007
Lexicon Pharmaceuticals Named One of the Best Places to Work by The Scientist
05/06/2007
Lexicon to Present at the BIO 2007 International Convention
«
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
»
Page 8 of 36
